U.S. stocks opened higher on Wednesday as traders monitor the latest developments in the Middle East and brace for the Federal Reserve’s latest rate policy decision.
The Dow Jones Industrial Average hovered around the flatline. The S&P 500 gained 0.1% along with the Nasdaq Composite.
Regencell Bioscience shares pulled back 23% in morning trading. The company’s year to date performance is off the charts too, having risen 59,900% in 2025. Its current market value of $36 billion tops Lululemon, eBay and Kraft Heinz. The shares traded for pennies at one point in the past one year.